Period Ending | Mar 30, 2012 | Dec 30, 2011 | Sep 29, 2011 | Jun 29, 2011 |
---|
Total Revenue
|
17,407,000
|
20,885,000
|
17,372,000
|
17,367,000
| Cost of Revenue | 3,952,000 | 5,638,000 | 3,777,000 | 3,708,000 | |
Gross Profit
|
13,455,000
|
15,247,000
|
13,595,000
|
13,659,000
| |
|
Operating Expenses |
|
Research Development | 2,517,000 | 2,371,000 | 2,329,000 | 2,393,000 |
|
Selling General and Administrative | 4,564,000 | 4,882,000 | 4,063,000 | 5,095,000 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
6,374,000
|
7,994,000
|
7,203,000
|
6,171,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (11,000) | 245,000 | 103,000 | 148,000 |
|
Earnings Before Interest And Taxes | 6,363,000 | 8,239,000 | 7,306,000 | 6,319,000 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 6,363,000 | 8,239,000 | 7,306,000 | 6,319,000 |
|
Income Tax Expense | 1,255,000 | 1,615,000 | 1,568,000 | 445,000 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 5,108,000 | 6,624,000 | 5,738,000 | 5,874,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
5,108,000
|
6,624,000
|
5,738,000
|
5,874,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
5,108,000
|
6,624,000
|
5,738,000
|
5,874,000
|
|